Sichuan Cancer Hospital — Chengdu, Sichuan

Public research footprint of Sichuan Cancer Hospital, compiled from the ClinicalTrials.gov public registry.

324

Registered studies

211

Active

125

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Non-small Cell Lung Cancer · Carcinoma, Non-Small-Cell Lung · Advanced or Metastatic Non-small Cell Lung Cancer · Solid Tumors

Recently updated registry entries

NCT06203210 — A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With… (Recruiting)
NCT05171647 — A Study Evaluating Efficacy and Safety of Mosunetuzumab in Combination With Polatuzumab… (Active Not Recruiting)
NCT04613596 — Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Sichuan Cancer Hospital?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.